Diametric Capital’s Boston Scientific BSX Stock Holding History

Diametric Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,015	Closed	-$574K	–	491
2025 Q4	$574K	Buy	+6,015	New	+$590K	0.15%	223
2023 Q1	–	Sell	-20,153	Closed	-$932K	–	359
2022 Q4	$932K	Buy	+20,153	New	+$873K	0.45%	71
2020 Q1	–	Sell	-45,827	Closed	-$2.07M	–	125
2019 Q4	$2.07M	Sell	45,827 -20,417	-31%	-$854K	1.51%	18
2019 Q3	$2.69M	Buy	66,244 +20,856	+46%	+$884K	2.22%	11
2019 Q2	$1.95M	Buy	45,388 +2,828	+7%	+$109K	1.24%	29
2019 Q1	$1.63M	Sell	42,560 -73,061	-63%	-$2.79M	1.28%	26
2018 Q4	$4.09M	Buy	115,621 +70,118	+154%	+$2.54M	3.15%	1
2018 Q3	$1.75M	Sell	45,503 -13,899	-23%	-$485K	1.52%	22
2018 Q2	$1.94M	Sell	59,402 -29,350	-33%	-$885K	1.83%	22
2018 Q1	$2.42M	Buy	88,752 +28,212	+47%	+$767K	1.83%	19
2017 Q4	$1.5M	Buy	+60,540	New	+$1.67M	0.91%	50

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Diametric Capital's BSX Position: Q1 2026 in Review

Diametric Capital sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,015 shares — an estimated $574K sold.

Diametric Capital first reported a position in BSX in Q4 2017 and held it in 11 quarters. The position peaked at $4.09M in Q4 2018. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Diametric Capital reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Diametric Capital sold 6,015 Boston Scientific shares in Q1 2026, an estimated $574K.
Diametric Capital first reported a position in Boston Scientific in Q4 2017 and held it in 11 quarters.
Diametric Capital's Boston Scientific position peaked at $4.09M in Q4 2018.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.